In a way, discovering and developing new medicines is hacking the code of biology – it can be incredibly challenging, like running a marathon full of ups and downs. Yet, we must not stop innovating and persevering for people in need. We are in this race together. We strive to bring life-changing medicines to patients and caregivers around the world.

I am a neuroscientist by training, a husband, and a father of two. I serve as Managing Director and Head of Business Development at RTW Investments, a preeminent healthcare investment firm. I help drive partnering, business development, and strategic transactions for RTW and its portfolio companies.

Prior to joining RTW, I was Global Head of Business Development & Alliances at Hansoh Pharma, responsible for expanding innovative pipeline through partnerships and broadening ex-Asia footprint, for which I built and led Hansoh’s U.S. discovery research site. Before Hansoh, I led Global Business Development at Hengrui Medicine, overseeing licensing, alliances, M&A, and strategic investment. Earlier in my career I advised pharmaceutical, biotech, and healthcare services companies as a member of Lazard’s healthcare investment banking group, executing complex M&A transactions, involving cross-border, shareholder activism, and restructuring situations.

I had the privilege to be a co-founder and President of The Biotechnology and Life Sciences Advising (BALSA) Group, a nonprofit consulting organization based in St. Louis, which established The BALSA Foundation to fund, support, and empower first-time entrepreneurs.